BRPI1006374A2 - "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib" - Google Patents

"processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib"

Info

Publication number
BRPI1006374A2
BRPI1006374A2 BRPI1006374A BRPI1006374A BRPI1006374A2 BR PI1006374 A2 BRPI1006374 A2 BR PI1006374A2 BR PI1006374 A BRPI1006374 A BR PI1006374A BR PI1006374 A BRPI1006374 A BR PI1006374A BR PI1006374 A2 BRPI1006374 A2 BR PI1006374A2
Authority
BR
Brazil
Prior art keywords
etoricoxib
purification
compound
preparation
polymorphic form
Prior art date
Application number
BRPI1006374A
Other languages
English (en)
Inventor
Pandey Bipin
Ghanshyambhai Dave Mayank
Shah Mitesh
Original Assignee
Cadila Healthcare Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltda filed Critical Cadila Healthcare Ltda
Publication of BRPI1006374A2 publication Critical patent/BRPI1006374A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI1006374A 2009-02-27 2010-01-25 "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib" BRPI1006374A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN441MU2009 2009-02-27
PCT/IN2010/000045 WO2010097802A2 (en) 2009-02-27 2010-01-25 A process for the preparation of etoricoxib

Publications (1)

Publication Number Publication Date
BRPI1006374A2 true BRPI1006374A2 (pt) 2019-09-24

Family

ID=42290121

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006374A BRPI1006374A2 (pt) 2009-02-27 2010-01-25 "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib"

Country Status (10)

Country Link
EP (2) EP2479166B1 (pt)
AR (1) AR075441A1 (pt)
BR (1) BRPI1006374A2 (pt)
DK (2) DK2479166T3 (pt)
ES (2) ES2562981T3 (pt)
HU (1) HUE028730T2 (pt)
MY (1) MY163020A (pt)
PL (2) PL2401253T3 (pt)
PT (1) PT2479166E (pt)
WO (1) WO2010097802A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012066570A2 (en) 2010-11-15 2012-05-24 Virdev Intermediates Pvt. Ltd. A process for cyclooxygenase-2 selective inhibitor
EA023286B1 (ru) * 2011-05-27 2016-05-31 ФАРМА ДжРС, Д.О.О. Способ получения полиморфной формы i эторикоксиба
EP2773618A1 (en) 2011-11-03 2014-09-10 Cadila Healthcare Limited An improved process for the preparation of etoricoxib and polymorphs thereof
GR1007973B (el) * 2012-06-26 2013-09-12 Φαρματεν Αβεε, Νεα ν-οξοιμινο παραγωγα ως ενδιαμεσα μιας βελτιωμενης μεθοδου παρασκευης 2,3-διαρυλο-5-υποκατεστημενων πυριδινων
WO2014114352A1 (en) * 2013-01-25 2014-07-31 Synthon Bv Process for making etoricoxib

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
US5739166A (en) 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
SI0912518T1 (en) 1996-07-18 2003-12-31 Merck Frosst Canada & Co. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US5861419A (en) 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
AU759469B2 (en) 1998-04-24 2003-04-17 Merck Sharp & Dohme Corp. Process for synthesizing cox-2 inhibitors
EP1248618B1 (en) 1999-11-29 2006-03-22 Merck Frosst Canada Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
PH12001001175B1 (en) 2000-05-26 2006-08-10 Merck Sharp & Dohme 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis
US6521642B2 (en) 2000-05-26 2003-02-18 Merck & Co., Inc. 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
JP2003160563A (ja) * 2001-11-29 2003-06-03 Sankio Chemical Co Ltd 新規な3−アミノ−2−プロペニリデンアンモニウム誘導体・bf4塩
WO2005085199A1 (en) 2004-01-14 2005-09-15 Cadila Healthcare Limited Novel polymorphs of etoricoxib

Also Published As

Publication number Publication date
HUE028730T2 (en) 2017-01-30
DK2401253T3 (en) 2016-04-18
ES2562981T3 (es) 2016-03-09
WO2010097802A3 (en) 2010-12-23
WO2010097802A2 (en) 2010-09-02
MY163020A (en) 2017-07-31
EP2401253B1 (en) 2016-01-13
EP2401253A2 (en) 2012-01-04
EP2479166A1 (en) 2012-07-25
EP2479166B1 (en) 2014-08-20
PL2401253T3 (pl) 2016-05-31
DK2479166T3 (da) 2014-09-01
PL2479166T3 (pl) 2014-11-28
PT2479166E (pt) 2014-11-28
ES2496465T3 (es) 2014-09-19
AR075441A1 (es) 2011-03-30

Similar Documents

Publication Publication Date Title
BRPI0911254A2 (pt) processo para a preparação de um composto
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
BRPI1010128A2 (pt) "processo para a fabricação do 2,3,3,3 - tetrafluropropeno"
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI1015061A2 (pt) "processo para a preparação contínua de isocianatos"
BRPI1012370A2 (pt) processo para a produção de olefinas
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI1006679A2 (pt) "processo para a preparação de um composto de estireno halogenado"
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BRPI0809652A2 (pt) Processo melhorado para a síntese de solifenacina
BRPI1013830A2 (pt) Processo para a iodação de compostos aromáticos
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI1008117A2 (pt) Processo para a sintese de cleistantina
BRPI0821837A2 (pt) Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas
BRPI0920705A8 (pt) processo para a produção de compostos alquilaromáticos
BR112012001731A2 (pt) Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol
BRPI1006374A2 (pt) "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib"
BRPI1010571A2 (pt) processo para a preparação de um composto útil como um inibidor de tafla.
BRPI0815971A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0921210A2 (pt) processos para a preparação de compostos de arilaminas
BRPI0914792A2 (pt) processo para a preparação de polióis
BR112012009611A2 (pt) ''processo para a preparação de um composto de fómula (i)''
BRPI0914400A2 (pt) "processo para a síntese de um composto"
BRPI0910595A2 (pt) processo para a produção de composto de pirimidina

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.